CN112841490A - Solid beverage with prolonged service life - Google Patents
Solid beverage with prolonged service life Download PDFInfo
- Publication number
- CN112841490A CN112841490A CN202110194057.XA CN202110194057A CN112841490A CN 112841490 A CN112841490 A CN 112841490A CN 202110194057 A CN202110194057 A CN 202110194057A CN 112841490 A CN112841490 A CN 112841490A
- Authority
- CN
- China
- Prior art keywords
- solid beverage
- powder
- life
- service life
- yeast
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 22
- 239000007787 solid Substances 0.000 title claims abstract description 21
- 230000002035 prolonged effect Effects 0.000 title claims abstract description 15
- 239000000843 powder Substances 0.000 claims abstract description 19
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 18
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 18
- 241000195620 Euglena Species 0.000 claims abstract description 16
- 241000195649 Chlorella <Chlorellales> Species 0.000 claims abstract description 13
- 241000168517 Haematococcus lacustris Species 0.000 claims abstract description 11
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 11
- 241000195633 Dunaliella salina Species 0.000 claims abstract description 10
- 240000002900 Arthrospira platensis Species 0.000 claims abstract description 9
- 235000016425 Arthrospira platensis Nutrition 0.000 claims abstract description 9
- 229940082787 spirulina Drugs 0.000 claims abstract description 9
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 8
- 235000021323 fish oil Nutrition 0.000 claims abstract description 7
- 240000008067 Cucumis sativus Species 0.000 claims abstract description 6
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 claims abstract description 6
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims abstract description 5
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims abstract description 5
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims abstract description 5
- 241000233866 Fungi Species 0.000 claims abstract description 5
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000005642 Oleic acid Substances 0.000 claims abstract description 5
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims abstract description 5
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims abstract description 5
- 238000002360 preparation method Methods 0.000 claims abstract description 4
- 235000013311 vegetables Nutrition 0.000 claims abstract description 3
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 10
- 239000001168 astaxanthin Substances 0.000 claims description 8
- 229940022405 astaxanthin Drugs 0.000 claims description 8
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 claims description 6
- 235000013793 astaxanthin Nutrition 0.000 claims description 6
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 3
- 239000008158 vegetable oil Substances 0.000 claims description 3
- 229920000855 Fucoidan Polymers 0.000 claims description 2
- 108010053210 Phycocyanin Proteins 0.000 claims description 2
- 238000009924 canning Methods 0.000 claims description 2
- 238000005303 weighing Methods 0.000 claims description 2
- 241000282414 Homo sapiens Species 0.000 abstract description 17
- 235000015097 nutrients Nutrition 0.000 abstract description 5
- 239000000463 material Substances 0.000 abstract description 2
- 230000000694 effects Effects 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 9
- 206010028980 Neoplasm Diseases 0.000 description 8
- 230000009286 beneficial effect Effects 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 230000036039 immunity Effects 0.000 description 6
- 208000024172 Cardiovascular disease Diseases 0.000 description 5
- 241000283973 Oryctolagus cuniculus Species 0.000 description 5
- 208000026106 cerebrovascular disease Diseases 0.000 description 5
- 230000002526 effect on cardiovascular system Effects 0.000 description 5
- 235000019197 fats Nutrition 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 208000007536 Thrombosis Diseases 0.000 description 4
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 4
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 229940116269 uric acid Drugs 0.000 description 4
- 201000005569 Gout Diseases 0.000 description 3
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 208000029078 coronary artery disease Diseases 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 2
- 208000004930 Fatty Liver Diseases 0.000 description 2
- 208000007882 Gastritis Diseases 0.000 description 2
- 206010019708 Hepatic steatosis Diseases 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 230000002155 anti-virotic effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 235000005473 carotenes Nutrition 0.000 description 2
- 150000001746 carotenes Chemical class 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229910052804 chromium Inorganic materials 0.000 description 2
- 239000011651 chromium Substances 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 208000010706 fatty liver disease Diseases 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 231100000240 steatosis hepatitis Toxicity 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 2
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 241000221377 Auricularia Species 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 230000006044 T cell activation Effects 0.000 description 1
- 230000006052 T cell proliferation Effects 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 1
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000037208 balanced nutrition Effects 0.000 description 1
- 235000019046 balanced nutrition Nutrition 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 208000003167 cholangitis Diseases 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- 229940110767 coenzyme Q10 Drugs 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229960002733 gamolenic acid Drugs 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 230000007160 gastrointestinal dysfunction Effects 0.000 description 1
- 208000018997 giddiness Diseases 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 229960001438 immunostimulant agent Drugs 0.000 description 1
- 239000003022 immunostimulating agent Substances 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 230000035777 life prolongation Effects 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000004199 lung function Effects 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 235000013557 nattō Nutrition 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000021315 omega 9 monounsaturated fatty acids Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 201000010041 presbyopia Diseases 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 201000000980 schizophrenia Diseases 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- 235000010930 zeaxanthin Nutrition 0.000 description 1
- 239000001775 zeaxanthin Substances 0.000 description 1
- 229940043269 zeaxanthin Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to the technical field of solid beverage preparation, and discloses a solid beverage with a prolonged service life, which comprises the following components: spirulina, chlorella, euglena, dunaliella salina, haematococcus pluvialis, vegetable oleic acid, deep sea fish oil, protein peptide, protein powder, yeast, cucumber seed powder and black fungus powder. The five-algae life-prolonging solid beverage provided by the invention uses medicinal and edible materials, provides high-quality nutrient elements for a human body, and can effectively prolong the life.
Description
Technical Field
The invention relates to the technical field of solid beverage preparation, in particular to a solid beverage with a prolonged service life.
Background
With the progress of science and technology, the development of society and the improvement of medical level, the life quality of people is better and better, the average life of society is gradually prolonged, however, after the average life reaches a certain critical point, the average life is prolonged very slowly, and the life of human beings is indicated to have a limit.
At present, no mature product and technology capable of prolonging the service life exist in China, the NMN in the U.S. at present prolongs the service life by 20-30 years, the principle is that the NMN enters human cells to become NAD, damaged cells are repaired, and the service life is prolonged, but the problems and the defects are obvious, and the cells are artificially manufactured and cannot improve diseases in the aspects of thrombus, inflammation and nervous system in blood vessels.
The solid beverage for prolonging the service life provided by the invention adopts a mode of combining Chinese traditional medicine and western medicine, provides high-quality complete nutrients and strong antioxidants for a human body, removes garbage in the body, has the functions of supplementing nutrition, expelling toxin and improving immunity, provides a good growth environment for cells, and is beneficial to realizing the purpose of prolonging the service life of human beings.
Disclosure of Invention
In view of the above, the invention provides a solid beverage with a prolonged service life, which uses materials with homology of medicine and food to provide high-quality nutrient elements for human bodies so as to achieve the purpose of prolonging the service life.
In order to achieve the purpose, the invention adopts the following technical scheme:
an extended life solid beverage comprising the following components: spirulina, Chlorella, Euglena, Dunaliella salina, Haematococcus pluvialis, vegetable oleic acid, deep sea fish oil, protein peptide, protein powder, yeast, cucumber seed powder, and Auricularia powder
The solid beverage with the prolonged service life comprises the following components in parts by weight: 60 g of spirulina, 60 g of chlorella, 30 g of euglena, 30 g of dunaliella salina, 30 g of haematococcus pluvialis, 60 g of vegetable oil acid, 30 g of deep sea fish oil, 60 g of protein peptide, 395 g of protein powder, 30 g of yeast, 30 g of cucumber seed powder and 15 g of black fungus powder.
Preferably, the spirulina contains at least 5% of phycocyanin.
The beneficial effects of the above technical scheme are that: the spirulina has comprehensive and balanced nutrition, has extremely high disease prevention and health care values, such as blood fat reduction, oxidation resistance, infection resistance, canceration resistance, radiation resistance, aging resistance and immunity enhancement, has certain resistance to pestilence haze, can protect intestines and stomach, resist tumors, prevent and inhibit cancers, prevent and treat hyperlipidemia, is beneficial to losing weight, eliminating fatty liver, preventing sun, treating anemia and the like.
Preferably, the dunaliella salina at least comprises 60% of fucoidan.
The beneficial effects of the above technical scheme are that: the dunaliella salina grows in severe saline water, contains dunaliella salina essence, is a good complete food, can adjust the acid-base balance of the body, contains rich mineral substances, various amino acids and dietary fibers, can adjust the pH value of cells, can treat coronary heart disease, cardiovascular and cerebrovascular diseases, prevent and treat cancers, and has good curative effects on headache, dizziness, dim eyesight, giddiness, numbness of limbs, hypodynamia, gastrointestinal dysfunction, blurred vision, gastric ulcer, gastritis, atrophic ulcer and the like, and can also improve the immunity, prolong the life of a human body, eliminate free radicals and slow down grief.
Preferably, the haematococcus pluvialis contains at least 2% astaxanthin.
The beneficial effects of the above technical scheme are that: the haematococcus pluvialis extract is L-astaxanthin, which can be divided into three types: the L-astaxanthin is extracted from haematococcus pluvialis, has the strongest oxidation resistance and the best effect of being taken by a human body, can effectively eliminate free radicals in cells, enhance the cell regeneration capacity, maintain the balance of the organism, reduce the accumulation of aged cells, protect the health of the human body from inside to outside, and has the effects of promoting hair growth, resisting aging, improving immunity, preventing tumors, cardiovascular and cerebrovascular diseases, diabetes, gout, gastrointestinal diseases, various eye diseases, cholangitis, diabetes and complications, so the service life can be prolonged.
The antioxidant activity of the natural astaxanthin is higher than that of the existing antioxidant, the capacity of scavenging free radicals is 6000 times of that of VC, 1000 times of that of VE, 800 times of that of coenzyme Q10, 1800 times of that of nitric oxide, 3100 times of that of natto, 100 times of anthocyanin, 100 times of B carotene, 10 times of lycopene and 320 times of tea polyphenol.
Astaxanthin can survive in a severe environment, survive for forty days after oxygen and water are cut off, and Haematococcus pluvialis can protect the life by generating a large amount of astaxanthin under the conditions of oxygen and water deficiency.
Preferably, the yeast is Saccharomyces cerevisiae
The beneficial effects of the above technical scheme are that: the beer yeast contains rich trivalent chromium, various diseases can be caused by the lack of the trivalent chromium, and diseases can be healed slowly by supplementing the trace elements.
The chlorella is a weakly alkaline food, has the effects of resisting oxidation and inflammation, improving cardiovascular and cerebrovascular diseases and improving lung function, contains nutrient components, and can quickly supplement physical strength and activate brain cells; the chlorella has the effect of expelling toxin, after eating the chlorella, harmful substances in blood of intestines, kidneys and lungs can be removed, and heavy metals in vivo can be eliminated, so that toxin expelling organs such as the liver and the kidneys are effectively protected; chlorella has anti-tumor effect, contains multiple proteins, can be used as immunostimulant to inhibit carcinogen toxicity, and can act together with host or receptor to promote T cell proliferation and activation by antigen specific immunity to enhance immunity; chlorella contains growth factor C.G.F, which can induce interferon to stimulate phagocyte, T cell and B cell in human body defense immune tissue, and enhance immune system function; the chlorella has good treatment effect on weak cancer patients, and patients with leukopenia and low immune function after radiotherapy and chemotherapy; the chlorella is rich in linoleic acid and gamma-linolenic acid, has the effects of regulating blood pressure and reducing blood fat, can prevent various chronic diseases, including atherosclerosis, coronary heart disease and the like, and can form a natural barrier for human health after being eaten.
The euglena is a high-adaptability organism, can live in a severe environment, contains 59 nutrient elements necessary for a human body, can comprehensively supplement nutrition required by the human body, relieve recessive hunger, provide vitamins, mineral substances, amino acids, unsaturated omega 3, euglena polysaccharide, lutein, zeaxanthin fat, GABA and the like, and is an efficient natural dietary nutrient supplement. The euglena has no cell wall and the absorption rate is up to 93.1 percent of the self dry weight.
The euglena can adsorb and inhibit purine, reduce the formation of gout uric acid, reduce the formation of ascorbic acid and dissolve the crystal of uric acid, and is a good food for treating gout.
The euglena polysaccharide has the effects of strong antioxidation, antivirus, tumor inhibition, aging delay and life prolongation, and the porous structure in the euglena polysaccharide can adsorb redundant substances in human bodies, such as cholesterol, neutral fat, heavy metal, alcohol, haze and the like, and helps to discharge the substances out of the body, so that the euglena polysaccharide has the effects of strong antioxidation, antivirus, free radical removal and various garbage removal.
The Euglena is one of a few algae capable of producing multiple vitamins simultaneously, including B carotene, vitamin C, and vitamin E, so that the Euglena has the effects of inhibiting tumor, prolonging life, and maintaining young state.
Omega 3 contains DHA and EPA, has the functions of cleaning thrombus and removing blood garbage, plant oleic acid exists in plants in large quantity, the plant oleic acid is converted into omega 3 in vivo after being eaten by people, omega 3 which can not be synthesized by the human body per se is provided, according to the research, 58 diseases of the human body are caused by the lack of omega 3 and comprise cardiovascular and cerebrovascular diseases, cancer, skin diseases, schizophrenia and the like, after omega 3 is supplemented, the state of an illness can be improved, omega 3 in the application is mainly from plants, fatty acid of the plants does not have omega 3, only after being eaten, the omega 3 can be synthesized through digestion, the fatty acid of animals directly contains omega 3, the fatty acid of the animals is directly absorbed after being eaten, and the animals and the plants are different.
The deep sea fish oil is from Norway, contains omega 3 and a small amount of omega 6 and omega 9, contains DHA and EPA, is beneficial to brain and eyes, and omega 3 can decompose fat, dissolve thrombus, has good curative effect on cardiovascular and cerebrovascular diseases, can not be synthesized by human body and is supplied from external source.
The protein powder is a carrier of the whole formula, has the functions of repairing and renewing cells, and is caused by the lack of protein in many diseases.
The protein peptide has smaller molecular weight than protein and is easy to absorb, the protein peptide can repair and renew cells after entering a human body, and astaxanthin and euglena can clean various wastes in the body to restore the health of people.
A preparation method of a solid beverage with a prolonged service life comprises weighing the raw materials according to a formula proportion, mixing uniformly, and canning, wherein each bag is filled with 20g of the canned beverage.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
The raw materials of the present invention are not particularly limited, and all of them are commercially available products.
Examples
The embodiment provides a solid beverage with a prolonged service life, which comprises the following components in parts by weight: 60 g of spirulina, 60 g of chlorella, 30 g of euglena, 30 g of dunaliella salina, 30 g of haematococcus pluvialis, 60 g of vegetable oil acid, 30 g of deep sea fish oil, 60 g of protein peptide, 395 g of protein powder, 30 g of yeast, 30 g of cucumber seed powder and 15 g of black fungus powder.
The drinking effect is as follows:
a lump grows on the neck of Wangzhi in the inspection institute of Shandong province, and the lump disappears after the formula is used for three months.
The blood sugar of the patient with Haerbin Zhang diabetes is measured by 8, the patient recovers three months after eating the formula, and the blood sugar is reduced to below 6.
The general manager of a company, Taian City, Shandong province, has more than 600 uric acid, and the uric acid is reduced to below 400 after the formula is eaten for three months, so that the pain is cured.
The inventor has the diseases of coronary heart disease, hypertension, thrombus blockage of lower limbs of both legs, heart failure, fatty liver, hyperlipidemia, skin diseases, eczema, kidney multiple cyst, gallbladder inflammation, cataract, presbyopia, gastritis and the like, and all the patients are recovered after eating the formula for five years.
The Teddy dog of 10 years old is mad, the Teddy dog recovers the health of the previous day by eating the formula for one year, the Teddy dog eating the test agent is 17 years old, the life of the Teddy dog is 12-13 years old according to the conventional life of the dog, and the service life of the Teddy dog eating the formula is prolonged by five years old.
The rabbits of 6 months age are divided into two groups, each group is divided into three rabbits, one group eats the formula group, the other group eats the foods without the formula as a control group, after four months, the rabbits which eat the formula group and the control group are dissected and divided into the meat quality, the rabbits which eat the formula group are fresh and tender in meat quality, and the rabbits of the control group are aged in meat quality and have sarcoma.
When a white mouse aged 10 months eats the formula for 6 months, the hair is white and glossy, the eyes are bright and have spirit, and no one side is ill.
When mice aged 10 months eat food without the formula for 6 months, the mice have dull hair, poor activity and individual diabetes.
The embodiments in the present description are described in a progressive manner, each embodiment focuses on differences from other embodiments, and the same and similar parts among the embodiments are referred to each other. The device disclosed by the embodiment corresponds to the method disclosed by the embodiment, so that the description is simple, and the relevant points can be referred to the method part for description.
The previous description of the disclosed embodiments is provided to enable any person skilled in the art to make or use the present invention. Various modifications to these embodiments will be readily apparent to those skilled in the art, and the generic principles defined herein may be applied to other embodiments without departing from the spirit or scope of the invention. Thus, the present invention is not intended to be limited to the embodiments shown herein but is to be accorded the widest scope consistent with the principles and novel features disclosed herein.
Claims (8)
1. A solid beverage having an extended life, comprising the following components: spirulina, chlorella, euglena, dunaliella salina, haematococcus pluvialis, vegetable oleic acid, deep sea fish oil, protein peptide, protein powder, yeast, cucumber seed powder and black fungus powder.
2. The solid beverage with the prolonged service life is characterized by comprising the following components in parts by weight: 60 g of spirulina, 60 g of chlorella, 30 g of euglena, 30 g of dunaliella salina, 30 g of haematococcus pluvialis, 60 g of vegetable oil acid, 30 g of deep sea fish oil, 60 g of protein peptide, 395 g of protein powder, 30 g of yeast, 30 g of cucumber seed powder and 15 g of black fungus powder.
3. The extended life solid beverage of claim 1, wherein said spirulina contains at least 5% phycocyanin.
4. The extended life solid beverage of claim 1, wherein said dunaliella salina includes at least 60% fucoidan.
5. The extended life solid beverage of claim 1, wherein said haematococcus pluvialis comprises at least 2% astaxanthin.
6. The extended life solid beverage of claim 1, wherein said yeast is brewer's yeast.
7. A preparation method of a solid beverage with a prolonged service life is characterized in that the solid beverage is obtained by respectively weighing each raw material according to a formula proportion, uniformly mixing and canning.
8. The method of claim 7, wherein the cans are filled in 20 g/bag.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110194057.XA CN112841490A (en) | 2021-02-20 | 2021-02-20 | Solid beverage with prolonged service life |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110194057.XA CN112841490A (en) | 2021-02-20 | 2021-02-20 | Solid beverage with prolonged service life |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112841490A true CN112841490A (en) | 2021-05-28 |
Family
ID=75988361
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110194057.XA Pending CN112841490A (en) | 2021-02-20 | 2021-02-20 | Solid beverage with prolonged service life |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112841490A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113519846A (en) * | 2021-07-16 | 2021-10-22 | 珠海中食果肽健康科技有限公司 | Fish oil extract multi-algae tablet capable of reducing blood fat and enhancing fat metabolism in vivo and preparation method thereof |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010120923A1 (en) * | 2009-04-14 | 2010-10-21 | Solazyme, Inc. | Novel microalgal food compositions |
CN104522828A (en) * | 2014-12-19 | 2015-04-22 | 上海承煌实业有限公司 | Alga ferment healthcare solid drink and preparation process thereof |
CN105559064A (en) * | 2015-12-23 | 2016-05-11 | 于蜀豪 | Five-alga probiotic enzyme tablets and preparation method thereof |
CN105724917A (en) * | 2014-12-10 | 2016-07-06 | 黑龙江众生生物工程有限公司 | Nutritional meal replacement powder containing spirulina components, and production method thereof |
CN108740680A (en) * | 2018-06-06 | 2018-11-06 | 唐山肽景堂生物科技有限公司 | The solid beverage preparation method of body peptide compounding is hindered in a kind of anti-movement |
CN111363658A (en) * | 2020-03-05 | 2020-07-03 | 何凤霞 | A beverage containing Haematococcus pluvialis extract (astaxanthin) and its preparation method |
-
2021
- 2021-02-20 CN CN202110194057.XA patent/CN112841490A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010120923A1 (en) * | 2009-04-14 | 2010-10-21 | Solazyme, Inc. | Novel microalgal food compositions |
CN105724917A (en) * | 2014-12-10 | 2016-07-06 | 黑龙江众生生物工程有限公司 | Nutritional meal replacement powder containing spirulina components, and production method thereof |
CN104522828A (en) * | 2014-12-19 | 2015-04-22 | 上海承煌实业有限公司 | Alga ferment healthcare solid drink and preparation process thereof |
CN105559064A (en) * | 2015-12-23 | 2016-05-11 | 于蜀豪 | Five-alga probiotic enzyme tablets and preparation method thereof |
CN108740680A (en) * | 2018-06-06 | 2018-11-06 | 唐山肽景堂生物科技有限公司 | The solid beverage preparation method of body peptide compounding is hindered in a kind of anti-movement |
CN111363658A (en) * | 2020-03-05 | 2020-07-03 | 何凤霞 | A beverage containing Haematococcus pluvialis extract (astaxanthin) and its preparation method |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113519846A (en) * | 2021-07-16 | 2021-10-22 | 珠海中食果肽健康科技有限公司 | Fish oil extract multi-algae tablet capable of reducing blood fat and enhancing fat metabolism in vivo and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102077936B (en) | Special sea dietary food for diabetics | |
CN102077934B (en) | Special dietary marine food for patients with high blood pressure | |
CN102077940B (en) | Special dietary marine food for patients with coronary heart disease | |
CN102077939B (en) | Marine special dietary food special for fat people | |
CN102077945B (en) | Special dietary seafood for postabortal and postpartum women | |
CN102077937B (en) | Special dietary seafood special for young and middle-aged women | |
CN102077938B (en) | Special marine dietary food for patients with liver deficiency | |
CN112089051A (en) | Nutritional composition for improving body inflammatory signs of tumor patients and preparation method thereof | |
CN101703248A (en) | Enteral nutritional preparation containing marine bioactivity polysaccharide as well as preparation method and application thereof | |
CN102077942B (en) | Marine special dietary food special for patient with bone disease | |
CN108056325B (en) | Sea water black porgy feed with immunity enhancing function | |
CN102077944B (en) | Marine special dietary food special for prostate patient | |
US20160151437A1 (en) | Nutritional supplements for improved vision and methods of treating the same | |
CN107616507A (en) | A kind of ocean polypeptide spy's dietary seafood for chornic arthritis edible for patients | |
CN107712537A (en) | A kind of lutein ester solid beverage | |
CN112841490A (en) | Solid beverage with prolonged service life | |
CN104431170A (en) | Marine bioactive polysaccharide or oligosaccharide granular tea drink for improving metabolic syndrome (six highs and one lipid) | |
CN106615769A (en) | Feed for producing pork containing DHA and use method thereof | |
CN102077943B (en) | Seafood for special dietary uses for hypomnesia patients | |
KR20180098888A (en) | Composition for increasing immunity having extract of peanut sprouts extract as active component | |
CN107549692A (en) | A kind of ocean polypeptide spy's dietary seafood for patients undergoing chemotherapy post-operative recovery | |
CN102077935B (en) | Marine special dietary food special for vision recession patient | |
Tou et al. | Novel Marine Sources of Nutraceuticals and Functional Foods: The Marine Crustacean Krill, Macro‐and Microalgae | |
CN102077941B (en) | Special dietary seafood special for climacteric women | |
CN105942069A (en) | Spirulina health-care beverage with immunity enhancing function and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210528 |